Workplace impacts of anti-TNF therapies in rheumatoid arthritis: review of the literature

Author： Birnbaum Howard   Shi Lizheng   Pike Crystal   Kaufman Rebecca   Sun Peter   Cifaldi Mary  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.10, Iss.2, 2009-02, pp. : 255-269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-TNF Treatment in Rheumatoid Arthritis

By  

Current Pharmaceutical Design, Vol. 17, Iss. 29, 2011-10 ,pp. : 3141-3151

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis

By Coenen Marieke JH   Toonen Erik JM   Scheffer Hans   Radstake Timothy RDJ   Barrera Pilar   Franke Barbara  

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 761-773

Future Medicine

Access to resources Recommend Favorite

Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs

By Avouac J   Allanore Y  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1121-1128

Informa Healthcare

Access to resources Recommend Favorite

Drug persistence, effectiveness and safety assessment of anti-TNF therapies in psoriatic arthritis

By Saad Amr A   Hyrich Kimme L   Ashcroft Darren M  

Expert Opinion on Drug Safety, Vol. 10, Iss. 2, 2011-03 ,pp. : 219-226

Informa Healthcare

Access to resources Recommend Favorite

Guidelines on the use of anti-tumour necrosis factor (TNF) therapies in patients with rheumatoid arthritis (RA) have been updated

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 475, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite